Among non-RCTs, seven studies applied lifestyle interventions aimed at increasing physical activity levels and decreasing energy intake, four studies combined CR with brisk walking, six studies combined CR with MICT (one incorporating a ketogenic diet), two studies combined CR with HIIT, and two studies combined CR with resistance training
Beyond heart health, GLP-1 agonists have also been shown to help the kidneys in people with type 2 diabetes and kidney disease
Tirzepatides safety profile, backed by larger trials, shows similar side effects but with proven real-world tolerability
Any changes in joint comfort that people experience while using these medications are related to changes in body weight or overall physical function rather than a direct effect on joint structures themselves
Sugiya, (2012), Oxidative Stress Environmental Induction and Dietary Antioxidants, Edited by Volodymyr I